Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

Guess Which City Tops the U.S. Travel Charts this July!

Daniel Kim Views  

With summer in full swing, Priceline, an online travel agency, has released data on the list of the most popular US travel destinations for the upcoming July holiday season.

Unsplash

Las Vegas was at the top of the list, making it the most popular travel destination for the July vacation period. Priceline added that affordable accommodation costs (an average nightly rate of $172) in Las Vegas make it one of the most affordable travel destinations.

Unsplash

New Orleans ranked second. The average cost of a hotel room in New Orleans is $390 per night. Orlando, known for its Walt Disney theme parks and numerous lakes, secured the third spot.

Kevin Heery, Chief Product Officer at Priceline, noted that the average hotel room cost in Orlando is currently $213 per night, with Chicago and New York City following at averages of $249 and $263 per night, respectively. He explained that while beach destinations were the most popular over the past two years, this summer marks a return to major cities. Heery highlighted that travelers are eager to return to metropolitan areas like Las Vegas, Chicago, and New York to enjoy the culture, entertainment, and culinary offerings.

According to Priceline, as of July 4, 2022, the average hotel rate increased by 18% compared to the same period in 2021. Round-trip by air within the United States in 2022 also increased by 32% from 2021.

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[LIFESTYLE] Latest Stories

  • Inside the Pope’s Health Crisis: Antibiotic-Resistant Infection Fuels Global Concern
  • Turns Out, What You Eat at 40 Really Can Shape How You Feel at 70
  • FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections
  • Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds
  • It’s Not Just Depression: Personality Disorders Linked to Highest Suicide Risk
  • Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout

Share it on...